Central Centrifugal Cicatricial Alopecia in Black Women: Diagnostic Challenges and Molecular Insights.
- 1Osteopathic Medical School, Nova Southeastern University Dr. Kiran C. Patel College of Osteopathic Medicine, Fort Lauderdale, USA.
- 2Department of Dermatology, HCA Florida Orange Park Hospital, Orange Park, USA.
Abstract
Central centrifugal cicatricial alopecia (CCCA) is a scarring alopecia that disproportionately affects Black women but remains underrecognized and frequently misdiagnosed because of its clinical overlap with other forms of hair loss. Emerging research has expanded the understanding of CCCA beyond its clinical presentation, highlighting the potential contribution of genetic susceptibility and disruptions in fibroinflammatory and metabolic pathways. A comprehensive literature review of publications from 2015 to 2025 identified 15 primary studies, supplemented by relevant reviews and case reports, addressing diagnostic features and evolving perspectives on disease pathogenesis. CCCA typically presents as progressive thinning of the central scalp and may resemble androgenetic alopecia or alopecia areata. Dermoscopy and histopathology remain important for accurate diagnosis, with findings that may include follicular dropout, perifollicular fibrosis, and lymphocytic inflammation. Molecular investigations have identified several pathways of interest, including those involving peptidyl arginine deiminase 3 (PADI3) and peroxisome proliferator-activated receptor gamma (PPAR-γ); however, their precise clinical significance continues to be investigated. Associations with autoimmune and metabolic comorbidities further support a multifactorial disease process involving genetic, inflammatory, and metabolic influences. Underrecognition may delay treatment and contribute to worse outcomes. Greater clinician awareness, culturally informed diagnostic approaches, and continued investigation of molecular mechanisms may support earlier detection, more individualized treatment, and reduced health disparities among women of color.
Related
- Struma Ovarii: Radiological Features and Diagnostic Challenges
- OA05 Complex polyostotic fibrous dysplasia in McCune-Albright syndrome: diagnostic and management challenges
- Diagnostic challenges of masked arginine vasopressin deficiency in neurosarcoidosis complicated by sodium–glucose cotransporter 2 inhibitor use
- Self-inflicted thoracoabdominal nail-gun injury presenting as STEMI: diagnostic challenges in a time-critical care pathway
- Pulmonary Epithelioid Trophoblastic Tumor Without Demonstrable Uterine Involvement: A Case Report and Literature Review Highlighting Diagnostic Challenges and Multidisciplinary Management
BibTeX
@article{persson2026central,
title = {{Central Centrifugal Cicatricial Alopecia in Black Women: Diagnostic Challenges and Molecular Insights.}},
author = {Calista Persson and Alexis Coican and Sarah Ferrer-Bruker},
journal = {Cureus},
year = {2026},
month = sep,
doi = {10.7759/cureus.116655},
url = {https://europepmc.org/article/MED/42910370},
note = {CC BY},
}
RIS
TY - JOUR
TI - Central Centrifugal Cicatricial Alopecia in Black Women: Diagnostic Challenges and Molecular Insights.
AU - Calista Persson
AU - Alexis Coican
AU - Sarah Ferrer-Bruker
PY - 2026
DA - 2026/09/21
JO - Cureus
DO - 10.7759/cureus.116655
UR - https://europepmc.org/article/MED/42910370
AB - Central centrifugal cicatricial alopecia (CCCA) is a scarring alopecia that disproportionately affects Black women but remains underrecognized and frequently misdiagnosed because of its clinical overlap with other forms of hair loss. Emerging research has expanded the understanding of CCCA beyond its clinical presentation, highlighting the potential contribution of genetic susceptibility and disruptions in fibroinflammatory and metabolic pathways. A comprehensive literature review of publications from 2015 to 2025 identified 15 primary studies, supplemented by relevant reviews and case reports, addressing diagnostic features and evolving perspectives on disease pathogenesis. CCCA typically presents as progressive thinning of the central scalp and may resemble androgenetic alopecia or alopecia areata. Dermoscopy and histopathology remain important for accurate diagnosis, with findings that may include follicular dropout, perifollicular fibrosis, and lymphocytic inflammation. Molecular investigations have identified several pathways of interest, including those involving peptidyl arginine deiminase 3 (PADI3) and peroxisome proliferator-activated receptor gamma (PPAR-γ); however, their precise clinical significance continues to be investigated. Associations with autoimmune and metabolic comorbidities further support a multifactorial disease process involving genetic, inflammatory, and metabolic influences. Underrecognition may delay treatment and contribute to worse outcomes. Greater clinician awareness, culturally informed diagnostic approaches, and continued investigation of molecular mechanisms may support earlier detection, more individualized treatment, and reduced health disparities among women of color.
SN - 2168-8184
ER -